Could fewer radiation doses be just as good for breast cancer?
NCT ID NCT02276885
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if a shorter course of radiation (3 doses over 5 days) is as safe and works as well as the standard 5-dose schedule for women with early-stage breast cancer. About 284 post-menopausal women with small, low-risk tumors took part. The main goal is to see if the shorter treatment causes less scarring (fibrosis) while still preventing cancer from coming back.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Medical Center
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?